Radiation and bio-detection technology group Kromek (KMK) is “pleased to have received… latest order for our D3S-ID nuclear radiation detector… from a US federal entity”. What of a current share price response up to 12.75p?...
Previously writing on group now describing itself as “a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments” Kromek (KMK), in July with the shares down towards 15p I reviewed “well-placed to capitalise on the substantial opportunities”, concluding still a sell. It today provides an update, with its year ended 30th April.
Kromek Group (KMK) has announced “new contracts and repeat orders across all of its target segments as commercial momentum continues to increase across the business”. Why then are the shares, heading towards 15p, currently more than 6% lower in response?...
Detection technology group Kromek (KMK) has announced “significant sequential revenue growth in H2 over H1 2020/21 and expects to report revenue and EBITDA for the year ended 30 April 2021 in line with market expectations. The group continues to maintain tight cost control, improve collections and manage cash flow, and this conscientious management has resulted in the group's cash position at 30 April 2021 being slightly ahead of market expectations”. Sounds good... but, with how creditable this performance is naturally dependent on the expectations, what are they?...
A “New Medical Screening and Nuclear Security orders” announcement from Kromek (KMK) and the shares currently at circa 17p. So what’s the outlook from here?...
Kromek (KMK) “is pleased to announce a conditional firm placing, directors' subscription and open offer to raise up to £13.0 million before expenses”. Should shareholders be pleased though?...
Previously writing on detection technology group Kromek (KMK), in November I concluded including I’d particularly review the receivable and inventory levels going forward here. Today results for the company’s half-year ended 31st October 2020...
A “wins new sector-leading global OEM customer” announcement from Kromek (KMK), with it “delighted to have secured another leading OEM customer with substantial global operations. This is further validation of the strength of our solutions”. What’s the impact re. a £40.5 million market capitalisation here...
